Synthetic peptide ELISAs for detection of and discrimination between group M and group O HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 13, Issue 12, 1997, Pages 987-993

  Mauclère, Philippe ^a   Damond, Florence ^b   Apetrei, Cristian ^b,c   Loussert Ajaka, Ibtissam ^b   Souquière, Sandrine ^b   Buzelay, Laurence ^d   Dalbon, Pascal ^e   Jolivet, Michel ^e   Mony Lobe, Marcel ^f   Brun Vézinet, Françoise ^b   Simon, François ^b   Barin, Francis ^d  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b BICHAT HOSPITAL   (France)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITÉ DE TOURS   (France)

^e BIOMÉRIEUX   (France)

^f Hopital Central de Yaounde   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; SYNTHETIC PEPTIDE;

ANTIGEN BINDING; ARTICLE; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROTYPING; VIRUS STRAIN;

EID: 0030792396     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.987     Document Type: Article

References (34)

1. Myers G, Hahn B, Mellors JW, et al.: Human Retroviruses and AIDS 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos National Laboratory, 1995.
2. Gürtler LG, Hauser PH, Eberle J, Von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994; 68:1581-1585.
3. Van den Haesevelde M, Decourt JL, De Leys RJ, Vanderborght B, van der Groen G, van Heuverswijn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994; 68:1586-1596.
4. Zekeng L, Gürtler L, Afane ZE, Sam-Abbenyi A, Mbouni-Essomba G, Mpoudi-Ngolle M, Monni-Lobe M, Tapko JB, and Kaptue L: Prevalence of HIV-1 subtype O infection in Cameroon: Preliminary results. AIDS 1994;8:1626-1628.
5. 70 virus in Cameroon and Gabon. AIDS 1993; 7:1536-1538.
6. Loussert-Ajaka I, Chaix ML, Korber B, Letourneur F, Gomas E, Allen E, Ly TD, Brun-Vézinet F, Simon F, and Saragosti S: Variability of HIV type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
7. Myers G: HIV: Between past and future. AIDS Res Hum Retroviruses 1994;10:1317-1324.
8. Peeters M, Gaye A, M'Boup S, Badornbena W, Bassabi K, Prince-David M, Develoux M, Liegeois F, van der Groen G, Saman E, and Delaporte E: Presence of HIV-1 group O infection in West Africa. AIDS 1996;10:343-344.
9. Hampl H, Sawitzky D, Stöffler-Meilicke M, Groh A, Schmitt A, Eberle J, and Gürtler L: First case of HIV-1 subtype O infection in Germany. Infection 1995;34:369-370.
10. Soriano V, Gutierrez M, Garcia-Lerma G, Aguilera O, Mas A, Bravo R, Perez-Labad ML, Baquero M, and Gonzalez-Lahoz J: First case of HIV-1 group O infection in Spain. Vox Sang 1996; 71:66.
11. Gould K, Britvan L, and Dryjansky J: HIV-1 group O infection in the USA. Lancet 1996;348:680-681.
12. Simon F, Ly TD, Baillou-Beaufils A, Schneider-Fauveau V, De Saint-Martin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Couroucé AM, Ingrand D, Janot C, and Brun-Vézinet F: Sensitivity of screening kits for anti-HTV-1 subtype O antibodies. AIDS 1994; 8:1628-1629.
13. Schable C, Zekeng L, Pau C-P, Hu D, Kaptue L, Gürtler L, Dondero T, Tsague JM, Schochetman G, Jaffe H, and George H: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;344:1333-1334.
14. Nyambi PN, Nkengasong J, Peeters M, Simon F, Eberle J, Janssens W, Fransen K, Willems B, Vereecken K, Heyndrickx L, Piot P, and van der Groen G: Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralise primary isolates of HIV-1 group M viruses. J Infect Dis 1995;172:1228-1237.
15. Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, and Bran-Vézinet F: HIV-1 group O sensitivity to antiretroviral drugs. AIDS 1995;9:977-978.
16. Loussert-Ajaka I, Decamps D, Simon F, Brun-Vézinet F, Ekwalanga M, and Saragoti S: Genetic diversity and HIV detection by polymerase chain reaction. Lancet 1995;346:912-913.
17. Janssens W, Fransen K, Loussert-Ajaka I, Heyndrickx L, Ivens T, Eberle J, and Nkengasong J: Diagnosis of HIV-1 group O infection by polymerase chain reaction. Lancet 1995;346:451-452.
18. Gürtler L: Difficulties and strategies of HIV diagnosis. Lancet 1996;348:176-179.
19. Simmonds P, Rose KA, and Graham S: Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): Use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993;31:1493-1503.
20. Barin F, Lahbabi Y, Buzelay L, Lejeune B, Baillou-Beaufils A, Denis F, Mathiot C, M'Boup S, Vithayasai V, Dietrich U, and Goudeau A: Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: An approach of HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 1996;12:1279-1289.
21. Hope DB, Murti VV, and du Vigneaud V: A highly potent analogue of oxytocin, desamino-oxytocin. J Biol Chem 1962;237:1563-1566.
22. Myers G, Korber B, Wain-Hobson S, Smith RF, and Pavlakis GN: Human Retroviruses and AIDS 1992. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1992.
23. Baillou A, Brand D, Denis F, M'Boup S, Chout R, Goudeau A, and Barin F: High antigenic cross-reactivity of the V3 consensus sequence of HIV-1 gp120. AIDS Res Hum Retroviruses 1993; 9:1209-1215.
24. Simon F, Loussert-Ajaka I, Damond F, Saragosti S, Barin F, and Brun-Vézinet F: HIV type 1 diversity in northern Paris, France. AIDS Res Hum Retroviruses 1996;12:1427-1433.
25. Mauclère P, Loussert-Ajaka I, Damond F, Fagot P, Souquières S, Mony-Lobe M, Mbopi Keou FX, Barré-Sinoussi F, Saragosti S, Brun-Vézinet F, and Simon F: Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS 1997; 11:445-453.
26. Lacassin F, Loussert-Ajaka I, Leport C, Vildé JL, and Simon F: Rapid fatal evolution in two cases of infection due to HIV-1 uncommon subtypes in France. AIDS 1996;11:267-268.
27. Cheingsong-Popov R, Callow D, Beddows S, Shaunak S, Wasi C, Kaleebu, Gliks C, Petrascu IV, Garaev MM, Watts DM, Constantine NT, and Weber JN: Geographic diversity of human immunodeficiency virus type 1: Serologic reactivity to env epitopes and relationships to neutralization. J Infect Dis 1992;165:256-261.
28. Cheinsong-Popov R, Lister S, Callow D, Kaleebu P, Beddows S, Weber J, and the WHO Network for HIV Isolation and Characterization: Serotyping HIV type 1 by antibody binding to the V3 loop: Relationship to viral genotype. AIDS Res Hum Retroviruses 1994; 11:1379-1386.
29. Nkengasong JN, Janssens W, Heyndrickx W, Fransen K, Ndumbe PM, Motte Leonaers A, Ngolle M, Ayuk J, Piot P, and van der Groen G: Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994; 8:1581-1585.
30. Gnann JW, McCormick JH, Mitchell S, Nelson JA, and Oldstone MBA: Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 1987;237:1346-1349.
31. Braaten D, Franke ER, and Luban J: Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIVcpzGAB but not group O HIV-1 or other primate immunodeficiency viruses. J Virol 1996;70:4220-4227.
32. Hirsch MS and Curran JW: Human immunodeficiency viruses. In: Virology (Fields BN, Knipe DM, Howley PM, et al., eds., 2nd ed. Lippincott-Raven, Philadelphia, 1996, pp. 1953-1976.
33. Charneau P, Borman AM, Quillent C, Guétard D, Chamaret S, Cohen J, Rémy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
34. Jonassen TØ, Stene-Johansen K, Berg ES, Hungnes O, Lindboe CF, Frøland SS, and Grinde B: Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997; 231:43-47.